FDA approves lisocabtagene maraleucel for second-line treatment of large B-cell lymphoma

[FDA]

FDA approves lisocabtagene maraleucel for second-line treatment of large B-cell lymphoma


Baca selengkapnya di : http://www.fda.gov...